Trials / Conditions / Pandemic H5N1 Influenza
Pandemic H5N1 Influenza
4 registered clinical trials studyying Pandemic H5N1 Influenza.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects NCT01766921 | Novartis Vaccines | Phase 2 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children NCT01776554 | Novartis Vaccines | Phase 2 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults NCT01776541 | Novartis Vaccines | Phase 2 |
| Completed | Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vacci NCT00914771 | Novartis Vaccines | Phase 2 |